Paul Hudson, Sanofi CEO (Romuald Meigneux/Sipa via AP Images)
July 5, 2022 01:56 PM EDTUpdated July 6, 07:46 AM
Pharma

Sanofi jump­starts ef­fort to sup­ply 30 'essen­tial' drugs to low­er-in­come coun­tries

Nicole DeFeudis

Editor

A week af­ter Sanofi promised to cut in­sulin prices, the phar­ma gi­ant’s non­prof­it unit is of­fer­ing more de­tails on its ef­fort to make the life …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Bio­Marin turns to ex-Roche deal­mak­er James Sabry to build ‘next ver­sion’ of 27-year-old com­pa­ny

Pur­due, Sack­lers reach new $7.4B opi­oid set­tle­ment af­ter SCO­TUS re­jec­tion

As an­oth­er Trump term gets un­der­way, phar­ma ad­vi­sors get com­fort­able with un­cer­tain­ty

Chi­na's biotech boom is threat­en­ing US drug­mak­er­s' dom­i­nance

Ab­b­Vie part­ners with Neo­morph in lat­est mol­e­c­u­lar glue deal

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times